{"name":"Walden Biosciences","slug":"walden-biosciences","ticker":"","exchange":"","domain":"walden.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxOdEhIV3lPamJHbFNhMmFsZTJHXzRMTGtHZUs0dV9lRTVQV0VDQmUwVEdDc0hReDZzcDVmLS1ONTRZa2dYWWR6R0V0dW9kd0xkQl9Da3d4T3lDZU9nSFNYTi1KV1MzWTc4WFpPbFJzby0zdDVMenV0dnZoejZDaXZxcGo5LTBpUFFQRVlRMEZXRlBtOENVV1ppSmlZTmYwQldsQUZSSzJWeWFrcW5oeUp3ZkZmanlzZmxKVWlVSWV2WElpNGV3THNfM0xDaW1yM3oteFFEdDVtREVZaElvZE9LR0JhaTkzTi1sVnpCc1hlaW5seXZ1V1FFRW4tQVRMN1NUbzVqU3doYlJjNG1MUm5EaDJ3TDJtLTNqWmNuNzBWZXVMUE16Nzl5STBCWQ?oc=5","date":"2026-04-06","type":"pipeline","source":"globenewswire.com","summary":"Idiopathic Membranous Nephropathy Market is Predicted to - globenewswire.com","headline":"Idiopathic Membranous Nephropathy Market is Predicted to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQMm9CRnUzemtISnZseWRBaFFGXy1XWTJHdmQzN0dIenY2WDZTXzhNaHc0VWpES2lWQXhNcVh6NFp5c1c3VTFqYUdRcE5HMmhHTlprWWtHSUhaRHBadEJ5bGpPZFB1OWZKYnFBeURyVnVsUnA3cGJiU3ZZNHFfUDIxVEpuWHNNUWdvZHRVREdmekphVE00UTNGMGE1NlR3d3JCTERMVl9OeXdYVTQ?oc=5","date":"2026-01-12","type":"pipeline","source":"Medscape","summary":"Looking Back: An Early IgA Case and How Care Has Evolved - Medscape","headline":"Looking Back: An Early IgA Case and How Care Has Evolved","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxQSnJER212eTJpZDFGRFFlUlZMZ1otNTgxM2VoR2ttOXhGb2p1b1NBcGcyT0VTZmJfY3FHYUdVWlA5bjlZZU82SENEZmJPLURXVUVtdjRyRXVLM1ZTVGxTclo2anZlcnhUU2NBdVJaclFuT1ZzRVRoTHFYWWM4ajJNNkFvQnhkcXdCRVBGYklGcUd1dEI2aTUtSGQxX0FPd2JwaHEwODgwSTVvY2M2c3M5a0tCX1JDSUhRd0pvMkFtS3A4ZVZuM0taSEdzOU5sbHIyNUdfWnFhVlpWOVF3UlNaZ3lXNXNaT1JUR1Q4WWRzYmsyNmZyY1g2ZW9B?oc=5","date":"2025-10-22","type":"regulatory","source":"PR Newswire UK","summary":"Glomerulonephritis Market Projected to Surge by 2034 with Rising Demand for Targeted Therapies | DelveInsight - PR Newswire UK","headline":"Glomerulonephritis Market Projected to Surge by 2034 with Rising Demand for Targeted Therapies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxNLU0wS3dENG4wZkNiSlpmeEk5YmNXOHpHTE45UlJLVjYxWVhGTU1PSl8xNFVONndVc0QyUzJUVjhpSU9maDhETEh3aXhwNktRSDVuWGNzRXpVSDhfSUtiT0dXdHloY2NWU19wcE5McTJVbHZHMlpQZ2tvbnpIUTE2MTYydFhONFhyUGRVUF8tSDJjR2hRWVM1MWRDbEs3alNGUXBOYmM3RmI3anpnM1ZmVDltdDdYa1lXeXZvUW9BZHFTT3hnQ0IyMHIzMl9MWFF5NkQzNDVpQWcxRGcwOGl5Tm1ycnNNVll5VW9JMkRpeUdfZWtQcGo5bzNUYm5CSDhXcjFZUGZISVBZUU1Zdl9SR2NOTWhEVGlzaEM4WGFSMnRSMnE0ZEgwRXBFYkdud0kyNkNJ?oc=5","date":"2025-09-04","type":"pipeline","source":"globenewswire.com","summary":"Walden Biosciences Announces Key Initiatives to Advance - globenewswire.com","headline":"Walden Biosciences Announces Key Initiatives to Advance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNaXRJQWQwX3lYcXVHX01hc1JYV2UwWjduY0I4bW1RSExkdVRaUFF0ZHJmQ1d4WEJGMDFsbnNPRms0eklHYTJIS2hRRFFGQ1VhMjlaNm5jZG9ZQ2Q1MG9WUjl4UnY2UjZpRnRfdGVJUzU0cWlhZlhYS2NtMmZtc0ZHbHNEMkNfbUE5N1JrZlhFZkR0VzBYZ3Z1V3Jtbw?oc=5","date":"2025-08-19","type":"trial","source":"Yahoo Finance","summary":"Focal Segmental Glomerulosclerosis Clinical Trial Pipeline Analysis Demonstrates 12+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - Yahoo Finance","headline":"Focal Segmental Glomerulosclerosis Clinical Trial Pipeline Analysis Demonstrates 12+ Key Companies at the Horizon Expect","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxOY3UwTFY2ZGI5ZXJNUEJVZ3o0ZThCdTFOWm5uN0t4QU0xOUVrOU8ySndNOER3Y2VhVWlDZUJZcWxlc3FpQUFzNERwdTEzdjJyTllyalNuVmwzbEJzX1RUN3hpUDZWZkg0X3VxZmRfYlhhS1M5VDZrLWRxZEJBdFkzSlpFU2NJY2VnRTBGMl9kT2l1aURLbXhLbGtfQXFqWU0wWllEV2RkdkN0TndsbE1iVzZWX1lReXFYZkNTaVJuQUJlXzFQSi1HNjA0Ti1kaVNDcUE4QXBJZU1OUVV3Znk3aHZjdmxMR0pLYjJMUzhPNE51SlcwVGVZcm5DSFl1UGYwb0t2SmJlM0l6TC16TV8ydTNsZlRqanRhbUxsbk9maU82RVpiSmRzeg?oc=5","date":"2025-06-10","type":"trial","source":"globenewswire.com","summary":"Diabetic Nephropathy Clinical Trial Analysis: Key Insights - globenewswire.com","headline":"Diabetic Nephropathy Clinical Trial Analysis: Key Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxOb3ZPVG82bTJTam8tQVFEeG04NTFoMEt6Y0Q0YS04VmhJSjNNMS1pQ003TU03djh3Ull1RnFSbERacjB1UC04MlVrRVFUNExwYVRyV3MzVy1qeThNdDBFd2lTckRaZW5zQXlrNVFYX0x3aTlJb0kybkhVb0lmZnprczV1b0sxOXhiVjh4bnpLYWpsWGhWSGVVMXoxWXQ5OHBXR1Bxc1Q0ME5MRDl4TEhvRVlTRzlqMzdyeHI1M2d3TUU1MVNUTEFieXo0b09OMVRjZ2lxWjAtY1FCRHhfMjNOc2ZjZTJJZHlD?oc=5","date":"2025-05-27","type":"pipeline","source":"PR Newswire","summary":"FILSPARI to Transform Kidney Disease Care with Its Revolutionary Treatment Approach | DelveInsight - PR Newswire","headline":"FILSPARI to Transform Kidney Disease Care with Its Revolutionary Treatment Approach | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNdVhvdW9DWFdrX2FSVzRBa0J5cWRUX1o2WVAxMGZqZlljNDF0bUJYd3VCV0JOSjFTcFNmb1o3YWRYYVNsNEV5UExOUDRJeTFiMjNNUGVuYjFIYmJBbzFQSGdSaGRFNHhJdk12N1lCMUJNeFZZb3NsUC1hZ1BxMTJnY1ZUcF9ITnNfVmtfSkozTDRBZ2Z6?oc=5","date":"2024-09-03","type":"pipeline","source":"pharmaphorum","summary":"4th annual Rare & Genetic Kidney Disease Drug Development Summit - pharmaphorum","headline":"4th annual Rare & Genetic Kidney Disease Drug Development Summit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOWkl1SGRkanJkZ0FsaXphdS0tRDNLZ3RVZjFQVVFRZWdtR0p6bTgzTkJINHJZakE3U1ZVYWNWMjdfQjN4RGFQN3R1VUZUQnNqZHBGaGtoem13VVVCcndiRC1US2FCcHdHd0dJc05oMXFoU2w4TTdscTREQ0hFRjVQWmRPb3Y0c3hjRHB6ZnU1dVo1U013TEJacThYOUJ3WS1PenBPSk5TV0JyTnRoUTlTNF91Zw?oc=5","date":"2024-05-14","type":"trial","source":"Pharmaceutical Technology","summary":"Walden Biosciences teams up with Primula for kidney disease study - Pharmaceutical Technology","headline":"Walden Biosciences teams up with Primula for kidney disease study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBiaEdUZUtPcXpJQUF3QlA2TldxS1lZMXRobmZ3ODNocEFXVV9HMGpBUl95NDFzRFJLaUtfM2dqQUxTSzVDcXhPYUZBRHFqX2tFSlVsNmJPVXBhSF81dzFj?oc=5","date":"2021-10-07","type":"pipeline","source":"nature.com","summary":"People - nature.com","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxORmU3RjdvLXdtNEFfOWJ2TkpYZHJkR0hwR290MGtfUzRPWGFwYXl6Y0piQnJ2b2U5bXNJZEg2eVBpVGdhazRvS2tQNXE3dVFBRHlDRURVQ1ptVG9XX2E2LWVlUnNLSUhweEx0ZVJ2amJfTDlOWU80WWRucFZYQS1KUHZMWTNtN3J6R3A5TXkzRGNmMmZvVDFVU01DcjA1NUFhUnc1bExUX09rNGV6RDB3?oc=5","date":"2020-10-06","type":"pipeline","source":"Fierce Biotech","summary":"Walden Biosciences launches with $51M and a 2-pronged approach to 'completely transform' kidney disease - Fierce Biotech","headline":"Walden Biosciences launches with $51M and a 2-pronged approach to 'completely transform' kidney disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPVVN5M3N5VDhkWENXUEVIMXNDVnpXRE5mMTU4RjNENzYtY2x6SEFzTFVZYS1QRHR3RUQ0UHV2RkdqNDhRaWdBcTI5UXpiRG1ONnppWWtFa1hTRU1UcDhIV05WX3dmak9TNDdFOEd1SXcwSHhjZGtYZE1TX2xHcndsYU8wRmRXU05ldU5rVDMxVmVlUzFqRzhXTEJndThtLWd4eC00Yi13RlBldmky?oc=5","date":"2020-10-06","type":"pipeline","source":"WSJ","summary":"Walden Biosciences to Fight Kidney Disease With $51 Million Series A - WSJ","headline":"Walden Biosciences to Fight Kidney Disease With $51 Million Series A","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}